Zacks Analyst Blog Highlights: SunPower, Solarfun, JA Solar, China Sunergy and Accuray - Press Releases

For Immediate Release

Chicago, IL – June 2, 2010 – Zacks.com Analyst Blog features: SunPower Corporation (SPWRA), Solarfun Power Holdings Co. Ltd. (SOLF), JA Solar Holdings Co. Ltd. (JASO), China Sunergy Co. Ltd. (CSUN) and Accuray Incorporated (ARAY).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

Another Contract for SunPower

SunPower Corporation (SPWRA) won a contract from the San Ramon Valley Unified School District (“SRVUSD") board of education to install high efficiency solar power systems totaling more than 3 megawatts (MW) at six schools in the district. Construction will be completed by the end of fiscal 2011.

SRVUSD encompasses the communities of Alamo, Blackhawk, Danville, Diablo, and San Ramon as well as a small portion of the cities of Walnut Creek and Pleasanton. The district comprises 34 schools serving more than 28,000 students in Kindergarten through Grade 12.

SRVUSD will finance the purchase of the systems using low interest bearing Qualified School Construction Bonds (QSCBs) available as a result of the federal American Recovery and Reinvestment Act of 2009 (ARRA). QSCBs allow schools to borrow at cheap rates for equipping, rehabilitation, and repair.

SunPower estimates the solar power generated by its solar power systems will offset an average of 80% of the electricity costs at each of the six schools, achieving an estimated savings of more than $2 million annually.

Headquartered in San Jose, California, SunPower designs, develops, manufactures, markets and sells high-performance solar electric power technology products, systems and services worldwide for residential, commercial and utility-scale power plant customers.

SunPower’s semiconductor-based solar cells and solar panels, which convert sunlight into electricity, are manufactured using proprietary processes and technologies.

The future of SunPower appears strong, given the revival of the alternative energy industry – specifically solar power energy – higher captive generation of panels, rising average conversion efficiency, declining silicon costs and assured silicon supply. Furthermore, state RPS requirements, stimulus plan and ITC grant underscore the SunPower story in the U.S.

In fiscal 2010, SunPower expects revenues in the range of $2.00 billion – $2.25 billion, with an adjusted EPS of $1.25 – $1.65. However the Zacks Consensus Estimate for fiscal 2010 presently stands at 82 cents with downward revisions all the way. We are apprehensive of the near-term performance of the company due to oversupply of modules in the market, subsidy risk in Germany and Italy, foreign currency risk, and the volatile economic environment in Europe.

SunPower generated 53% of its revenue from European customers in fiscal 2009. Per company estimates, a 10% change in the euro exchange rate would have impacted its revenue by approximately $81 million in fiscal 2009.

SunPower is also trading at a premium compared with its peers such as Solarfun Power Holdings Co. Ltd. (SOLF), JA Solar Holdings Co. Ltd. (JASO) and China Sunergy Co. Ltd. (CSUN), based on forward earnings estimates. The above peers, we believe, are more promising in the near term compared with the Zacks Rank #3 (“Hold") SunPower stock.

Accuray's CyberKnife Installed

Accuray Incorporated (ARAY) recently reported the installation of the first CyberKnife VSI System at Creekside Cancer Care in Lafayette, Colorado. The CyberKnife VSI System is the latest addition to Accuray’s CyberKnife family of products.

The new system will enable the Creekside Cancer Care center to offer expanded cancer treatment options from radiosurgery to high-precision radiation therapy. The Creekside Cancer Care center will begin treating patients with the CyberKnife VSI System from June 2010.

The new CyberKnife VSI System is touted to have a unique combination of speed and accuracy. The time taken to deliver a radiosurgery plan may be lowered by up to 50% without compromising accuracy, claims Accuray. The new system has fastened the ability to track and correct for tumor motion, which is important for treating lung cancer. This allows a greater number of patients to be treated non-invasively.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com